ClinicalTrials.Veeva

Menu

Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units (TRANSCOV)

E

Ecole des Hautes Etudes en Santé Publique

Status

Unknown

Conditions

Covid19

Treatments

Other: Inter ICU long distance patient transfer

Study type

Observational

Funder types

Other

Identifiers

NCT04930120
20 CO 015 CZ

Details and patient eligibility

About

The TRANSCOV cohort is a multicentre observational retrospective study aiming at assessing the health impact of extra regional transfers of critically ill COVID-19 patients.

Full description

In spring 2020 four regions of France faced a surge of severe Coronavirus (COVID) patients which threatened to overflow local intensive care units (ICU) capacities. As an emergency response, between 03/13/2020 and 04/10/2020, an estimated 661 patients were transferred from overcrowded ICUs to other French regions and neighbouring countries. The study aims at assessing the impact of these inter-ICU transfers on the short and medium term physical and psychological outcomes in this population of severe COVID 19 patients.

All transferred patients between ICUs outside the origin region are invited to take part. For each transfer, up to four control patients will be selected among those admitted in the same ICU during the same period (+/-4 days of transfer date). Clinical data will be extracted from medical records and will include hemodynamic and respiratory parameters, as well as clinical severity scores before, during and after transfer. Data linkage with medico-administrative data will enrich the clinical database and allow follow-up up to one year after initial admission.

Enrollment

3,060 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COVID-19 patients diagnosed biologically or by imaging
  • Admission in ICU between 03/13/2020 and 04/10/2020

Exclusion criteria

  • none

Trial design

3,060 participants in 2 patient groups

Transferred group
Description:
The transferred group includes all severe COVID patients admitted in a French ICU ward and then transferred between the 03/13/2020 and 04/10/2020 to another ICU located outside the region of the initial ICU stay.
Treatment:
Other: Inter ICU long distance patient transfer
Control group
Description:
The control group includes patients selected out of those whose entire ICU care has taken place in one of the hospitals which transferred patients. Up to 4 control patients will be selected for each transferred patient.

Trial contacts and locations

1

Loading...

Central trial contact

Olivier Grimaud, Ph.D., M.D; Christophe Fermanian, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems